Hungarian National Systemic Amyloidosis Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSemmelweis University
About this trial
This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.
Eligibility criteria
Qualifiers
Diagnosis of systemic amyloidosis
Patients aged ≥18 years at the time of enrollment
Signed informed consent form by the patient
Treating physician's consent
Disqualifiers
Lack of informed consent in the prospective study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov